Prime Medicine (PRME) Revenue (2024 - 2026)

Prime Medicine has reported Revenue for 3 years, with the latest figure at $856000.0 in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 41.13% year-over-year to $856000.0; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 4.89% YoY), and the FY2025 full-year result was $4.6 million, up 55.28% from the prior year.
• Revenue for Q1 2026 stood at $856000.0, up from $838000.0 in the prior quarter.
• The five-year high for Revenue was $2.2 million in Q4 2024, with the low at $209000.0 in Q3 2024.
• Historically, Revenue has averaged $1.1 million across 3 years, with a median of $985500.0 in 2025.
• The largest YoY upside for Revenue was 486.12% in 2025 against a maximum downside of 61.61% in 2025.
• Prime Medicine's Revenue stood at $2.2 million in 2024, then tumbled by 61.61% to $838000.0 in 2025, then advanced by 2.15% to $856000.0 in 2026.
• The last three Revenue figures came in at $856000.0 (Q1 2026), $838000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.